Vidcast: https://youtu.be/X1W4-0N-sRs
The FDA has approved the oral medicine fezolinetant, branded as Veozah, as an effective treatment for severe vasomotor symptoms brought on by menopause. This age is a neurokinin 3 receptor antagonist that effectively shields the receptor that controls body temperature. The pill should be taken once a day, each day at the same time. The drug’s effectiveness and safety were determined in two randomized, controlled, double-blinded trials.
https://www.fda.gov/news-events/press-announcements/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause